Jump to Navigation

Facebook Connect

User login

Communications CSS

Lipid Luminations on ReachMD

To listen to the most recent Lipid Luminations episodes, visit the ReachMD website here.

Guest Virgil Brown, MD with Host Alan S. Brown, MD

Is there a patient age at which statin therapy should be discontinued? Likewise, what does the current evidence tell us about initiating vs not initiating statin therapy in older patients? Joining Lipid Luminations to discuss these and other important questions is Dr. W. Virgil Brown, Charles...

Air Date: January 30, 2015
3
Average: 3 (1 vote)
Guest Monica Marin, MD with Host Alan S. Brown, MD

Obesity is associated with systemic inflammation and oxidative stress, the leading steps towards development of atherosclerosis. Myloperoxidase (MPO) mediated oxidative damage of high-density lipoprotein (HDL) leads to a dysfunctional HDL which likely becomes pro-atherogenic. But, what happens...

Air Date: January 5, 2015
0
No votes yet
Guest Joshua W. Knowles, MD, PhD with Host Alan S. Brown, MD

Speaking with host Dr. Alan Brown on the state of genetic testing for familial hypercholesterolemia (FH) is Dr. Joshua W. Knowles, MD, PhD, Instructor of Cardiovascular Medicine at Stanford University and Attending Physician of the Stanford Center for Inherited Cardiovascular Disease Familial...

Air Date: December 22, 2014
0
No votes yet
Guest Marc Hamilton, MD with Host Larry Kaskel, MD

Host Dr. Alan Brown welcomes Dr. Marc Hamilton, Professor at Pennington Biomedical Research Center in Baton Rouge, LA. Their convesation focuses on the cardiometabolic consequences of lengthy sitting times, such as in people with "desk job careers."

Air Date: December 15, 2014
0
No votes yet
Guest Dr. Harold Bay with Host Alan S. Brown, MD

Dr. Harold Bays, Chair for the National Lipid Association's expert panel on Adiposity, Obesity, and Dyslipidemia, discusses with host Dr. Alan Brown the panel's consensus statement published in the Journal of Clinical Lipidology.

Air Date: December 1, 2014
0
No votes yet
Guest John Guyton, MD with Host Alan S. Brown, MD

As many as 25% of patients taking statins may experience side effects. How should clinicians respond to the broad spectrum of side effects and variable severities reported? Host Dr. Alan Brown welcomes Dr. John Guyton, Associate Professor of Medicine and Assistant Professor of Pathology at Duke...

Air Date: November 17, 2014
0
No votes yet
Guest Kevin Maki, PhD, FNLA, CLS with Host Alan S. Brown, MD

A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-...

Air Date: November 10, 2014
0
No votes yet
Guest Kevin Maki, PhD, FNLA, CLS with Host Alan S. Brown, MD

What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA...

Air Date: November 3, 2014
0
No votes yet
Guest Carl Orringer, MD, FACC, FNLA with Host Alan S. Brown, MD

What are some of the causes of high triglycerides? What is the biggest health risk? And, for these patients, at what level is the risk greater for developing pancreatitis and coronary artery disease? Host Dr. Alan Brown welcomes Dr. Carl Orringer, Associate Professor of Medicine at the...

Air Date: October 27, 2014
0
No votes yet
Guest Revathi Balakrishnan, MD, MPH with Host Alan S. Brown, MD

Joining Dr. Alan Brown is Revathi Balakrishnan, MD, MPH, a general cardiology fellow at NYU and winner of the NLA Young Investigator Competition. Dr. Balakrishnan's research, titled "Prevalence of unrecognized prediabetes, diabetes and metabolic syndrome in patients undergoing non-urgent PCI...

Air Date: October 20, 2014
0
No votes yet

Pages



by Dr. Radut.